中文     English
Haisight Investment Limited, the joint stock company of Haisco Pharmaceutical Group(002653),will acquire 26.66% equity of MST with US $10,500,000.

 

  Haisight Investment Limited, the joint stock company of Haisco Pharmaceutical Group002653),has signed SERIES C SHARE PURCHASE AGREEMENTwith Medical Surgery Technologies Limited (MST). Under this agreement, Haisight Investment Limited intends to acquire 26.66% equity of MST with US $10,500,000. MST is the leading medical device R&D Company in Israel. The leading product of MST is AutoLap, an image-guided laparoscope intelligent positioning system for laparoscopic surgery. According to the agreement, Haisco Pharmaceutical Group shall get the exclusive right to sell AutoLap in China for 15 years.

 

For more information, please contact us at jun.yuan@bfcgroup.biz